Specialties
Reports that name this provider
- Alternative Cancer Treatment Availability in Japan
- Operates the GanJoho Service portal. Public cancer hospital distinct from private alternative clinics.
- Cancer Screening Quality in Japan
- Japan's apex oncology institution. International patient access exclusively through seven authorized medical coordinating agents including Medical Access Japan, JTB Medical & Healthcare, and i-cell Networks. Second opinions cost JPY 132,000 (approximately USD 880).
- Cancer Treatment Cost Savings in Japan
- International patients charged 30 yen per medical point (vs. 10 yen insured rate). Requires full prepayment. Provides second-opinion consultations (¥132,000/$880) and pathological consultations (¥148,500–¥181,500/$990–$1,210). Designated coordinating agents required for non-native Japanese speakers. Part of Japan International Hospitals (JIH) certification network.
- Integrative Oncology Quality in Japan
- Requires all international patients to use designated medical coordinating agents. Services conducted in Japanese; international patients without Japanese interpreters are directed to other facilities
- Pathology Quality in Japan
- Provides pathological consultations to international patients at JPY 148,500 (standard) or JPY 181,500 (with additional diagnosis), including consumption tax. Second-opinion consultations available at JPY 132,000. Requires Japanese-language communication capability for clinical interaction. Pathology department holds ISO 15189 and CAP accreditation.
- Second Opinion Services in Japan
- Charges ¥132,000 for standard second opinion and ¥148,500–¥181,500 for pathological consultations. Works with seven government-authorised medical coordinating agents. Hosts the ATLAS Asia Clinical Trials Network for international cancer case consultations and clinical trial matching.